ClinicalTrials.gg
RecruitingNCT05957549Updated Jul 10, 2025

Tracking Early Emergence of Sound Perception Impairments in FXS With Multimodal fNIRS/EEG-Preschool Age

An interventional study of Speech discrimination in Fragile X Syndrome, sponsored by Children's Hospital Medical Center, Cincinnati. Recruiting at 1 site in United States. Open to participants aged 24 Months to 4 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-10.

Sponsored by Children's Hospital Medical Center, Cincinnati · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Registered 8 months after the study started (first participant enrolled Oct 2022, registered Jul 2023).
  • Started Oct 2022; still recruiting 4 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Not applicable
Ages
24 Months to 4 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 82 studies in Fragile X Syndrome with a site in United States — 11 open to participants now, 16 under way, 2 of them phase 3. Fragile X Syndrome · United States.

Planned enrollment
23rd of 68
90 · median 60
Started
2022
with 6 others
No phase
14 of 82
6 open now
Primary completion
2027-03
later than 7 of 15 live
Registered
71st of 82
by date
Lead sponsor
8 of 82
Children's Hospital Medical Center, Cincinnati

Among the 82 studies in Fragile X Syndrome with a site in United States, this one is the 23rd largest by planned enrollment of the 68 interventional ones that give a count, is one of 7 that started in 2022, is one of 14 with no phase, reaches primary completion later than 7 of the 15 other live ones, and was the 71st registered.

Fragile X Syndrome

115 studies on the registry are indexed under Fragile X Syndrome; 25 are open to participants now.

Browse Fragile X Syndrome studies →

Open to participants now

11 of the 82 studies in Fragile X Syndrome with a site in United States are open now. Recruiting first, the newest first:

5 more — sign in →

All 11 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 18 Fragile X Syndrome studies recruiting now, 5 (28%) set no upper age limit and 13 (72%) stop at 75 or younger; 15 take children under 18; 7 take healthy volunteers.

This study: 24 Months to 4 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 82 studies in Fragile X Syndrome with a site in United States, or all of them as a file.
02

Study summary

Individuals with Fragile X Syndrome show differences in how they understand and learn language from infancy. They frequently have lifelong delays in speech and language as well. In addition, they experience other auditory symptoms, including being very sensitive to certain sounds as well as being more sensitive than others to loud sounds. The underlying brain activity for sound perception and speech learning in Fragile X is not well understood, especially in the infant, toddler, and preschool years. This study uses behavioral assessment of speech and language abilities, neuroimaging, and hearing tests to understand how speech and hearing are different in children with Fragile X Syndrome.

Read the detailed description

Fragile X Syndrome (FXS) is the leading monogenic cause of intellectual disability and autism and is associated with extremely high risk for early delays in speech and language. While early childhood is essential for speech and language development, neural mechanisms for language impairments have been studied entirely in older children and adults with FXS. Therefore, markers for speech and language impairments are unavailable in young children with FXS to predict severity, test potential mechanisms, and track response to intervention. The investigators have identified a hallmark brain-based phenotype of hyperresponsiveness to sounds in adolescents and adults with FXS. This fundamental alteration in cortical responses to sound could influence early language delays, but this phenotype has not been explored in infants or toddlers with FXS.

Specifically, in this study the investigators will use simultaneous EEG/fNIRS during presentation of simple speech, stories, and nonspeech sounds to quantify and localize auditory hypersensitivity and neural differentiation in 30 preschoolers with FXS. The investigators will assess specificity through comparison with 30 typically developing controls and 30 mental-age matched children with a history of premature birth and language delays.

03

Conditions studied

  • Fragile X Syndrome

Browse trials for

04

Who can participate

Ages eligible
24 Months to 4 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnoses of Fragile X Syndrome, Typical Development, or History of Premature Birth
  • able to sit independently
  • English is spoken at home

Exclusion criteria

Exclusion Criteria:

  • For all participants: no seizures in the past 6 months
  • For typical development group and Fragile X group: not born prior to 32 weeks gestation
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Speech Sounds

    Participants listen to speech sounds while the investigators measure electrical and hemodynamic changes in the brain.

    Other: Speech discrimination

Interventions

  • OtherSpeech discrimination

    Two different speech sounds are played at the same sound intensity.

06

What researchers measure

Primary outcomes

  1. Change in Mullen Scales of Early Learning

    change in Mullen Scales scores (age-corrected) from baseline on all subscales, including Expressive Language, Receptive Language, FIne Motor, Gross Motor, and Visual Reception. T-Scores from the Mullen Scales of Early Learning (MSEL) have a mean of 50 and a standard deviation of 10. Range=20-80. Higher scores indicate more advanced developmental skills.

    Time frame: at single study visit between ages of 2-4 years inclusive

  2. Changes in oxygenated and deoxygenated hemoglobin concentration in response to sounds in language regions of the brain

    Relative increase in oxygenated versus deoxygenated hemoglobin for no sounds, low intensity sounds, and medium intensity sounds. Measured via functional Near Infrared Spectroscopy with optodes placed over frontal, temporal, and parietal language regions.

    Time frame: at single study visit between ages of 2-4 years inclusive

  3. Changes in amplitude of mismatch negativity response during sound discrimination

    Electroencephalography is measured over the scalp while participant listens to speech sounds with infrequent "oddball" stimuli. Amplitude of the P100 for all stimuli as well as amplitude of the mismatch negativity response (frequent minus infrequent response) as well as change in these metrics over development are tracked in all groups.

    Time frame: at single study visit between ages of 2-4 years inclusive

  4. Changes in hearing thresholds

    Hearing thresholds in dB as assessed using Conditioned Play Audiometry (CPA) or Visual Reinforced Audiometry (VRA) dependent on child age and developmental ability.

    Time frame: at single study visit between ages of 2-4 years inclusive

  5. Otoacoustic Emissions (OAEs)

    Signals produced by excitation of hair cells in cochlea are measured for a range of frequencies.

    Time frame: at single study visit between ages of 2-4 years inclusive

  6. Changes in tympanometric pressure profile in the inner ear

    Wide Band Tympanometry is completed to measure variability in tympanometric pressure for left and right ears that may affect hearing profile.

    Time frame: at single study visit between ages of 2-4 years inclusive

Secondary outcomes

  1. Sensory profile 2 Auditory Processing subtest

    parent-report measure of child's behavioral responses to sounds in their environment

    Time frame: at single study visit between ages of 2-4 years inclusive

  2. Sensory Profile 2 Attentional subtest

    parent-report measure of child's awareness of and responses to sensory cues in their environment.

    Time frame: at single study visit between ages of 2-4 years inclusive

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified information will be shared as required for NIH grant supported studies.

Supporting information: Study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2022 (actual). Primary completion is estimated for Mar 2027, 52 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 3, 2023
First posted
Jul 24, 2023
StartActual
Oct 4, 2022
Primary completionEst.
Mar 1, 2027
CompletionEst.
Mar 1, 2027
Last update
Jul 10, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05957549
Responsible party
Sponsor
First posted
Jul 24, 2023
Start date
Oct 4, 2022
Primary completion
Mar 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Jul 10, 2025

Study contacts

Elizabeth Smith, PhD
Contact
elizabeth.smith3@cchmc.org
5135171383
Craig Erickson, MD
Contact
craig.erickson@cchmc.org
5136366553

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion